A high-quality platform for guidelines on clinical decisions.
A high-quality platform for guidelines on clinical decisions. Led by the China National Cancer Center, the editors ensure authentic statistics, consensus, and guidelines for clinical reference. Cancer Innovation combines professional resources to close the shortcomings in the management of oncological comorbidities.